Genetic Testing in Breast Cancer
- Nyhet
Innovations in Diagnosis and Treatment
Häftad, Engelska, 2026
2 159 kr
Kommande
Genetic Testing in Breast Cancer: Innovations in Diagnosis and Treatment explores the pressing demands in breast cancer care for advanced, less invasive diagnostic tools that facilitate early detection and effective monitoring of therapeutic progress. With a particular emphasis on triple-negative breast cancer (TNBC), the book presents a thorough examination of the latest advancements in genetic testing, such as next-generation sequencing and the Sanger method. By analyzing these technologies, the volume demonstrates how they are fundamentally transforming both the early diagnosis process and the customization of treatment plans for individuals affected by breast cancer.
The book provides practical case studies, encompassing other breast cancer subtypes, including HER2-positive cases. It addresses the integration of genetic testing into clinical practice, discusses hereditary mutations, and underscores the importance of genetic counseling. The editors also highlight ongoing challenges and emerging opportunities in the field, ensuring that students, researchers, oncologists, pharmacologists, and healthcare professionals gain a comprehensive understanding.
The book provides practical case studies, encompassing other breast cancer subtypes, including HER2-positive cases. It addresses the integration of genetic testing into clinical practice, discusses hereditary mutations, and underscores the importance of genetic counseling. The editors also highlight ongoing challenges and emerging opportunities in the field, ensuring that students, researchers, oncologists, pharmacologists, and healthcare professionals gain a comprehensive understanding.
- Explores the latest genetic testing strategies, including next-generation sequencing and the Sanger method for early and accurate breast cancer diagnosis and treatment
- Includes practical preclinical and clinical case studies that demonstrate the application of genetic testing for various breast cancer subtypes, such as TNBC and HER2-positive breast cancer
- Provides in-depth insights into the challenges and opportunities in integrating genetic testing into clinical practice, with a focus on personalized treatment plans
Produktinformation
- Utgivningsdatum2026-03-01
- Mått191 x 235 x undefined mm
- Vikt450 g
- FormatHäftad
- SpråkEngelska
- Antal sidor330
- FörlagElsevier Science
- ISBN9780443278013